← Leaderboards

Lea K Davis

Massachusetts General Hospital

Google Scholar ↗PubMed ↗ORCID ↗

$7,633,493

Attributed

$14,507,048

Total exposure

7

Grants

5

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY2019–25

$5M$3.8M$2.5M$1.3M$0

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$14,507,048 · 7

By mechanism

R01$11,676,619 · 4

R56$1,635,118 · 1

P50$1,195,311 · 2

Top collaborators

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Jordan W Smoller$49,248,068
Pamela Sklar$31,628,187
Stephen V Faraone$22,345,408
Schahram Akbarian$48,610,378
Timothy E Wilens$10,413,097

Others in their field

Other Emerging Leaders on “Biobank”

Leonard Freedman · Leidos Biomedical Research, Inc.$247,215,881
Lynn Briscoe · Leidos Biomedical Research, Inc.$95,456,386
Leonard Freedmand · Leidos Biomedical Research, Inc.$55,787,452
Scott Topper · Broad Institute, Inc.$46,919,719
Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220

Research focus

BiobankGenome Wide Association StudyGeneticRisk FactorsPhenotypeGenomicsResearch PersonnelMental DisordersCommunitiesBaseComputerized Medical RecordElectronic Health RecordLinkComorbidityClinically RelevantBiologicalResourcesDiagnosticMedicalGenesInfrastructureDiagnosisInnovationSite

Grant awards (22)

2/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact$972,987

R01 · FY2025 · MH

1/7-PsycheMERGE: Advancing Precision Psychiatry$579,175

R01 · FY2025 · MH · contact PI

2/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact$1,144,691

R01 · FY2024 · MH

1/7-PsycheMERGE: Advancing Precision Psychiatry$608,962

R01 · FY2024 · MH · contact PI

Elucidating the phenome-wide impact of sex and gender on disease$427,256

R01 · FY2024 · HG · contact PI

Improving precision use of antipsychotic medication in people with autism$222,447

P50 · FY2024 · HD · contact PI

2/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact$1,030,221

R01 · FY2023 · MH

Elucidating the phenome-wide impact of sex and gender on disease$436,330

R01 · FY2023 · HG · contact PI

Improving precision use of antipsychotic medication in people with autism$240,204

P50 · FY2023 · HD · contact PI

2/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact$1,087,458

R01 · FY2022 · MH

PsycheMERGE: Leveraging electronic health records and genomics for mental health research$741,890

R01 · FY2022 · MH

Elucidating the phenome-wide impact of sex and gender on disease$436,371

R01 · FY2022 · HG · contact PI

Improving precision use of antipsychotic medication in people with autism$240,204

P50 · FY2022 · HD · contact PI

2/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact$1,195,691

R01 · FY2021 · MH

PsycheMERGE: Leveraging electronic health records and genomics for mental health research$750,379

R01 · FY2021 · MH

Elucidating the phenome-wide impact of sex and gender on disease$618,182

R01 · FY2021 · HG · contact PI

Improving precision use of antipsychotic medication in people with autism$240,103

P50 · FY2021 · HD · contact PI

Mental health and chronic disease: A psycheMERGE investigation into the shared biology underlying psychiatric disorders and their physical comorbidities$804,559

R56 · FY2020 · MH · contact PI

PsycheMERGE: Leveraging electronic health records and genomics for mental health research$791,339

R01 · FY2020 · MH

Improving precision use of antipsychotic medication in people with autism$252,353

P50 · FY2020 · HD · contact PI

PsycheMERGE: Leveraging electronic health records and genomics for mental health research$855,687

R01 · FY2019 · MH

Mental health and chronic disease: A psycheMERGE investigation into the shared biology underlying psychiatric disorders and their physical comorbidities$830,559

R56 · FY2019 · MH · contact PI